Skip to main content
TipRanks
Go Ultimate75% OFF

Fusion Antibodies Plc (FAB) Ownership - Who Owns Fusion Antibodies Plc?

10 Followers

Fusion Antibodies Plc (FAB) Ownership Overview

  • 4.55% Insiders
  • 95.45% Public Companies and Individual Investors

The ownership structure of Fusion Antibodies Plc (GB:FAB) stock is a mix of institutional, retail, and individual investors. , 4.55% is owned by Insiders, and 95.45% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Jan 26, 2026Adrian Kinkaid£23,847
Jan 26, 2026Colin James Walsh£19,862
Jan 26, 2026Richard John Buick£16,287

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

GB:FAB top shareholders
Holder# of SharesType% HoldingValue
Colin James Walsh3,531,785Insider2.82%194,248
Richard John Buick1,125,282Insider0.90%61,891
Adrian Kinkaid1,033,438Insider0.83%56,839

FAQ

What percentage of Fusion Antibodies Plc (GB:FAB) stock is held by retail investors?
According to the latest TipRanks data, approximately 95.45% of Fusion Antibodies Plc (GB:FAB) stock is held by public companies and individual investors.
Who owns the most shares of Fusion Antibodies Plc (GB:FAB)?
Colin James Walsh owns the most shares of Fusion Antibodies Plc (GB:FAB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.